MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/jaa.s422836

Медицинская библиотека · Journal of asthma and allergy · 2023

Successful Treatment of Atopic Dermatitis with a Predominant Nipple Involvement by Abrocitinib During COVID-19 Pandemic: A Case Report.

Teng Yan, Tang Hui, Yu Yong, Fan Yibin, Tao Xiaohua, Xu Danfeng

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND

There is limited literature on AD with a predominant involvement of nipple among the adult male group. SARS-CoV-2 infection might have been an exacerbating factor of AD by initiating the "cytokine storm". Conventional treatment suffers from a dilemma of poor efficacy and a high recurrence. The JAK inhibitors have been clinically applied to treat the AD with a good outcome.

PATIENTS AND

METHODS

We present a case of a 28-year-old male AD patient with a predominant nipple involvement successfully treated with JAK inhibitor abrocitinib, with no adverse affects.

RESULTS

The case shows a good clinical efficacy of JAK inhibitor abrocitinib in the treatment of AD with a predominant nipple involvement during the COVID-19 pandemic with a rapid and long-term symptomatic relief.

CONCLUSION

JAK inhibitor abrocitinib might become a promising agent for the treatment with AD with a predominant uncommon region like nipple that might be resistant to conventional therapies during the COVID-19 pandemic.

Для цитирования: Teng Yan, Tang Hui, Yu Yong, Fan Yibin, Tao Xiaohua, Xu Danfeng. Successful Treatment of Atopic Dermatitis with a Predominant Nipple Involvement by Abrocitinib During COVID-19 Pandemic: A Case Report.. Journal of asthma and allergy. 2023. DOI: 10.2147/jaa.s422836.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.